RESUMEN
"Gluten sensitivity" has become commonplace among the public. Wheat allergy (WA) and celiac disease (CD) are well-defined entities, but are becoming a fraction of individuals following a gluten-free diet (GFD). Wheat allergy has a prevalence of <0.5%. Wheat, specifically its omega-5 gliadin fraction, is the most common allergen implicated in food-dependent, exercise-induced anaphylaxis. CD is a non-IgE hypersensitivity to certain cereal proteins: gluten in wheat, secalin in rye, hordein in barley, and to a lesser extent avenin in oat. It is a rare disease, with an estimated prevalence that varied widely geographically, being higher in Northern Europe and the African Saharawi region than in South-East Asia. In addition to suggestive symptoms, serologic testing has high diagnostic reliability and biopsy is a confirmatory procedure. Patients with CD have extra-intestinal autoimmune comorbid conditions more frequently than expected. A third entity is nonceliac gluten sensitivity, which has been created because of the increasing number of subjects who claim a better quality of life or improvement of their variety of symptoms on switching to a GFD. The phenomenon is being fueled by the media and exploited by the industry. The lack of a specific objective test has been raising substantial controversy about this entity. Allergists and gastroenterologists need to pay attention to the multitudes of individuals who elect to follow a GFD. Many such subjects might have WA, CD, or another illness. Providing them with appropriate evaluation and specific management would be of great advantages, medically and economically.
Asunto(s)
Alérgenos/inmunología , Alergólogos , Enfermedad Celíaca/inmunología , Grano Comestible/efectos adversos , Glútenes/inmunología , Hipersensibilidad al Trigo/inmunología , Enfermedad Celíaca/diagnóstico , Enfermedad Celíaca/epidemiología , Enfermedad Celíaca/terapia , Comorbilidad , Consejo Dirigido , Manejo de la Enfermedad , Humanos , Fenotipo , Triticum/efectos adversos , Hipersensibilidad al Trigo/diagnóstico , Hipersensibilidad al Trigo/epidemiología , Hipersensibilidad al Trigo/terapiaRESUMEN
SUMMARY: We describe the case of a 24-year-old male with hyper-IgE syndrome (HIES) which was diagnosed at 4 years of age and died from a very rare cardiac complication. He had typical clinical and laboratory manifestations of HIES, including total serum IgE as high as > 100,000 IU/mL. Stem cell transplantation was not available. During the 20-year follow-up, he suffered numerous various infections of the skin and deep organs, partial lung resection, as well as multiple bone fractures. At age 24, he developed acute decompensated heart failure associated with elevated serum troponin I and brain natriuretic protein. Two-dimensional echocardiogram revealed global hypokinesis of the left ventricle with estimated ejection fraction 20-25%, and catheterization revealed ectasia of multiple coronary arteries. Endomyocardial biopsy showed lymphocytic myocarditis, focal necrosis, mild fibrosis, and myxoid degeneration, but cultures were negative. The patient improved on corticosteroid therapy and was discharged on heart failure therapy and external defibrillator. Six weeks later, he developed supraventricular tachycardia and persistent global hypokinesis and was treated with amiodarone. A trial of intravenous immunoglobulin was initiated and was repeated as outpatient every four weeks for four times. However, his cardiac function did not improve and he developed severe hypotension and pulseless electrical activity arrest. Resuscitation was unsuccessful. To the best of our knowledge, this is the first reported case of HIES complicated with lymphocytic myocarditis. Both immunologists and cardiologists need to be aware of such a complication and practice caution in using immunosuppressants when the patient's immune status is markedly compromised.
Asunto(s)
Hipergammaglobulinemia/inmunología , Inmunoglobulina E/inmunología , Síndrome de Job/inmunología , Miocarditis/inmunología , Biopsia , Resultado Fatal , Humanos , Hipergammaglobulinemia/complicaciones , Hipergammaglobulinemia/diagnóstico , Huésped Inmunocomprometido , Inmunoglobulina E/sangre , Inmunosupresores/administración & dosificación , Inmunosupresores/efectos adversos , Síndrome de Job/complicaciones , Síndrome de Job/diagnóstico , Masculino , Miocarditis/diagnóstico , Miocarditis/fisiopatología , Miocarditis/terapia , Resultado del Tratamiento , Adulto JovenRESUMEN
Several seeds have been increasingly incorporated in various food items, with consequent risk of hypersensitivity reactions that are often severe. Identification of the specific seed as the culprit is often not explored or is difficult to verify. In this article, we reviewed the English literature from January 1930 to March 2016 using PubMed and Google Scholar searching for publications relevant to hypersensitivity to common edible seeds, namely sesame, sunflower seed, poppy seed, pumpkin seed, flaxseed, and mustard seed. Considering the worldwide consumption of those seeds, the number of published articles on the subject was relatively small and was mainly as case reports rather than large series. Allergy to sesame was more reported than to other seeds, with an estimated prevalence of 0.1-0.2%. In this review, we summarize the information relevant to each of the six seeds and their oils regarding the manifestations, routes of exposure, identified major allergens, and cross-reactivity with other seeds or other foods. We also addressed the important role of a thorough history taking in suspecting seed allergy, the limited reliability of routine diagnostic procedures, and the importance of verification by appropriate challenge tests. At present, management is basically dietary avoidance and the use of symptomatic medications that may include epinephrine auto-injectors. We did not encounter any well-designed studies on immunotherapy for seed allergy, but it is hoped that such a gap be filled by the development of safe effective protocols in the near future.
Asunto(s)
Alérgenos/inmunología , Grano Comestible/efectos adversos , Hipersensibilidad a los Alimentos/diagnóstico , Hipersensibilidad a los Alimentos/inmunología , Semillas/efectos adversos , Sesamum/efectos adversos , Anafilaxia/diagnóstico , Anafilaxia/inmunología , Reacciones Cruzadas/inmunología , Diagnóstico Diferencial , Manejo de la Enfermedad , Hipersensibilidad a los Alimentos/epidemiología , Hipersensibilidad a los Alimentos/terapia , Humanos , Hipersensibilidad Inmediata/diagnóstico , Hipersensibilidad Inmediata/inmunología , Inmunoglobulina E/inmunologíaRESUMEN
BACKGROUND: Food allergy has been gaining increasing attention, mostly as causing gastrointestinal and cutaneous reactions. Its role in asthma seems to be under-recognised. OBJECTIVES: This study's aim is to explore the frequency of involvement of a common food, namely cow's milk, in childhood asthma. METHODS: 32 children (5 months to 11 years; median 24 months; mean 34 months) with asthma and a suspected history of cow's milk allergy were studied. They underwent skin prick testing (SPT) and specific IgE (sIgE) testing to whole cow's milk (WCM), casein, α-lactalbumin, and ß-lactoglobulin, followed by single-blind oral milk challenge. RESULTS: Reactions to milk challenge occurred in 12 (37.5%) including wheezing in 5 (41.7%, or 15.6% of the whole group). Children who developed wheezing at the time of challenge were younger than those who had negative challenge (23.0 months vs. 34.8 months). Challenge was positive in 33.3% of subjects who had a positive SPT, and SPT was positive in 50% of challenge-positive subjects. Regarding sIgE, challenge was positive in 26.7% of sIgE-positive subjects, and sIgE was positive in 33.3% of challenge positive subjects. Skin or serum testing with individual protein fractions did not seem to add significant advantage over testing with WCM alone. CONCLUSION: This study shows that cow's milk can cause wheezing in children with asthma. Although SPT seemed to be more reliable than sIgE testing, both had suboptimal reliability. It is worth considering possible milk allergy in children with asthma, particularly when poorly controlled in spite of proper routine management.
Asunto(s)
Asma/inmunología , Hipersensibilidad a la Leche/inmunología , Alérgenos/inmunología , Animales , Asma/complicaciones , Asma/diagnóstico , Bovinos , Niño , Preescolar , Femenino , Humanos , Inmunoglobulina E/sangre , Lactante , Recién Nacido , Masculino , Hipersensibilidad a la Leche/complicaciones , Hipersensibilidad a la Leche/diagnóstico , Proteínas de la Leche/inmunología , Prevalencia , Ruidos Respiratorios/etiología , Pruebas CutáneasRESUMEN
BACKGROUND: The placebo-controlled study International Multicentre Prospective Angioedema C1-INH Trial 1 (I.M.P.A.C.T.1) demonstrated that 20 U/kg C1 esterase inhibitor (C1-INH) concentrate (Berinert®; CSL Behring, Marburg, Germany) is effective in treating acute abdominal and facial Hereditary Angioedema (HAE) attacks. METHODS: I.M.P.A.C.T.2 was an open-label extension study of I.M.P.A.C.T.1 to evaluate the safety and efficacy of long-term treatment with 20 U/kg C1-INH for successive HAE attacks at any body location. Efficacy outcomes included patient-reported time to onset of symptom relief (primary) and time to complete resolution of all symptoms (secondary), analysed on a per-patient and per-attack basis. Safety assessments included adverse events, vital signs, viral safety and anti-C1-INH antibodies. RESULTS: During a median study duration of 24 months, 1085 attacks were treated in 57 patients (10-53 years of age). In the per-patient analysis, the median time to onset of symptom relief was 0.46 h and was similar for all types of attacks (0.39-0.48 h); the median time to complete resolution of symptoms was 15.5 h (shortest for laryngeal attacks: 5.8 h; 12.8-26.6 h for abdominal, peripheral and facial attacks). Demographic factors, type of HAE, intensity of attacks, time to treatment, use of androgens and presence of anti-C1-INH antibodies had no clinically relevant effect on the efficacy outcomes. There were no treatment-related safety concerns. No inhibitory anti-C1-INH antibodies were detected in any patient. CONCLUSIONS: A single dose of 20 U/kg C1-INH concentrate is safe and provides reliable efficacy in the long-term treatment of successive HAE attacks at any body location.
Asunto(s)
Angioedemas Hereditarios/tratamiento farmacológico , Proteína Inhibidora del Complemento C1/uso terapéutico , Adolescente , Adulto , Anticuerpos/inmunología , Niño , Proteína Inhibidora del Complemento C1/administración & dosificación , Proteína Inhibidora del Complemento C1/efectos adversos , Femenino , Humanos , Masculino , Persona de Mediana Edad , Resultado del Tratamiento , Adulto JovenRESUMEN
BACKGROUND: Studies on serum IgE levels during pregnancy are limited. OBJECTIVE: To investigate the course of serum total IgE levels during pregnancy and postpartum. METHODS: 159 pregnant subjects provided 218 serum samples during various stages of pregnancy and the postpartum period. Serum total IgE geometric means were compared at various trimesters and postpartum. In addition, the postpartum IgE data were analysed according to the method of delivery. Analysis was also done according to history of allergy. RESULTS: The geometric mean serum total IgE was 20.5 IU/ml in the first trimester, 20.8 IU/ml in the second and 22.2 IU/ml in the third. Postpartum serum IgE level showed a lower mean, 14.9 IU/ml during the early postpartum period (less than 30 days) compared to 30.3 IU/ml during the late postpartum period (30 days-25 weeks). However this was not statistically significant. Serum IgE in the postpartum period also did not differ according to method of delivery. A history of allergy was positive in 98 samples, negative in 61 and unclear in 59. Using analysis of variance, none of these three groups showed significant change in serum total IgE level during pregnancy or postpartum. CONCLUSION: In this cross-sectional study, serum total IgE levels showed no statistically significant changes during pregnancy or postpartum. This finding would be of greater weight if reproduced in a larger number of subjects with multiple serial samples at fixed regular time intervals during pregnancy and postpartum.
Asunto(s)
Inmunoglobulina E/sangre , Periodo Posparto/sangre , Complicaciones del Embarazo/sangre , Adolescente , Adulto , Estudios Transversales , Parto Obstétrico , Femenino , Humanos , Periodo Posparto/inmunología , Embarazo , Complicaciones del Embarazo/inmunología , Trimestres del Embarazo , Adulto JovenRESUMEN
BACKGROUND: The role of genetics in allergy development is well accepted. However, studies could not delineate the mode of inheritance or what is specifically being inherited. The purpose of this study was to determine the effect of genetics on the development of allergy manifestation, serum IgE level, and sensitization to specific allergens. METHODS: Fifty-eight twin sets (age 7 months to 11 years) were evaluated for allergy by medical history, family history, physical examination, serum total IgE level, and percutaneous testing to selected common allergens. RESULTS: In 25 monozygotic (MZ) sets, concordance of atopy was significantly higher than in 33 dizygotic (DZ) sets (84.6% vs 62.5%). The age at onset tended to be earlier when the mother was allergic than when the father was (23.5 months vs 30.5 months). When both twins were allergic, the intra-pair difference in age at onset was within <6 months in 50% of MZ sets versus 31.8% in DZ sets. Total IgE level in twins showed a very strong correlation in MZ sets (r 0.92), but only a moderate correlation among DZ sets (r 0.57). Skin test positivity to specific allergens did not show a significant concordance between twins in either group. CONCLUSION: Our study indicates that the genetic influence was strongest on the inheritance of IgE phenotype, the development of the atopic tendency, the age of onset, and to some extent on the specific allergy manifestation. The effect seemed less on determining the specific offending allergen(s), suggesting possible roles of epigenetic and environmental factors.
Asunto(s)
Alérgenos/inmunología , Enfermedades en Gemelos/genética , Hipersensibilidad/genética , Inmunoglobulina E/genética , Gemelos Dicigóticos/genética , Gemelos Monocigóticos/genética , Edad de Inicio , Niño , Preescolar , Enfermedades en Gemelos/inmunología , Humanos , Hipersensibilidad/inmunología , Inmunización , Inmunoglobulina E/sangre , Inmunoglobulina E/inmunología , Lactante , Rinitis/genética , Rinitis/inmunología , Pruebas Cutáneas , Gemelos Dicigóticos/inmunología , Gemelos Monocigóticos/inmunologíaRESUMEN
Food allergy is one of several causes of adverse reactions to foods. The underlying immunologic mechanism varies from one manifestation to another, hence no current single laboratory test can be expected to be positive in every case. The diagnosis could be suggested by information gathered from the medical history or screening procedures, such as trials of elimination diets, the food/symptom diary, skin testing, and in vitro-specific IgE antibody measurement. All foods suspected by any of the aforementioned methods should be subjected to verification by appropriate elimination-challenge testing, preferably in a double-blind, placebo-controlled manner. Basically, treatment is dietary elimination, and its success requires identification and avoidance of all offending foods and control of other contributory factors.
Asunto(s)
Hipersensibilidad a los Alimentos , Anticuerpos/análisis , Hipersensibilidad a los Alimentos/diagnóstico , Hipersensibilidad a los Alimentos/fisiopatología , Hipersensibilidad a los Alimentos/terapia , Humanos , Inmunoglobulina E/análisis , Prueba de Radioalergoadsorción , Pruebas CutáneasRESUMEN
With the recent resurgence of breast-feeding, the medical profession has been facing numerous questions regarding the advantages, limitations and practicality of this mode of infant feeding. The recent identification in human milk of "growth modulators" has probably augmented its nutritional superiority. Several psychosocial advantages of breast-feeding have also become well recognized. The increasing knowledge on the immunologic quality of human milk has contributed a great deal to the explanation of the long noticed lower morbidity and mortality in breastfed infants. Several benefits have also been recognized for the nursing mother herself. On the other hand, problems in breast-feeding may arise from conditions either in the infant or in the mother. Only a few such conditions constitute absolute obstacles to breast-feeding. In promoting breast-feeding, a leading role should be exercised by the medical profession assisted by a responsible role for the formula manufacturers and a supporting role for the women's organizations.
Asunto(s)
Lactancia Materna , Estudios de Evaluación como Asunto , Femenino , Sustancias de Crecimiento/análisis , Educación en Salud , Humanos , Lactante , Alimentos Infantiles , Fenómenos Fisiológicos Nutricionales del Lactante , Recién Nacido , Comercialización de los Servicios de Salud , Leche Humana/análisis , Leche Humana/inmunología , Relaciones Madre-Hijo , Embarazo , Grupos de AutoayudaRESUMEN
Interest in food allergy has increased among physicians as well as the public. The symptoms are mainly in the gastrointestinal tract, the skin, and the respiratory system. Other organs are less commonly affected. The offending food can be suspected from the medical history, by skin testing, or by serum-specific IgE antibodies (RAST). Verification, however, depends on documentation of disappearance of symptoms after avoidance of the offending food and their recurrence on reintroduction of that food. Treatment is mainly dietary avoidance. Its success, however, depends on many factors. Pharmacologic agents may be needed in some cases for symptomatic relief and possibly for prophylaxis. The awareness on the part of the primary physician of the manifestations of food allergy and its diagnosis should enhance the physician's expertise in dealing with such patients regarding further management.
Asunto(s)
Hipersensibilidad a los Alimentos , Adulto , Anafilaxia/etiología , Angioedema/etiología , Preescolar , Hipersensibilidad a los Alimentos/diagnóstico , Hipersensibilidad a los Alimentos/etiología , Hipersensibilidad a los Alimentos/terapia , Humanos , Inmunoglobulina E/análisis , Lactante , Prueba de Radioalergoadsorción , Hipersensibilidad Respiratoria/etiología , Pruebas Cutáneas , Urticaria/etiologíaRESUMEN
Food sensitivity is only one of several types of food-related reactions. Symptoms are not pathognomonic; hence, a broad differential diagnosis is often considered. Unless the anticipated reaction is systemic anaphylaxis, the role of any food suspected (by history, skin testing, and/or radioallergosorbent test) of causing the patient's symptoms should be verified by elimination-challenge testing. Dietary elimination is the most effective treatment, but its success depends on several factors.
Asunto(s)
Hipersensibilidad a los Alimentos , Aditivos Alimentarios/efectos adversos , Hipersensibilidad a los Alimentos/diagnóstico , Hipersensibilidad a los Alimentos/etiología , Hipersensibilidad a los Alimentos/terapia , Humanos , Inmunoglobulina E/análisis , Prueba de Radioalergoadsorción , Pruebas Cutáneas , Glutamato de Sodio/efectos adversos , Sulfitos/efectos adversosRESUMEN
The role of food allergy in the respiratory tract is often underestimated. A wide variety of food-induced respiratory symptoms has been described. In some patients, a food additive rather than a food protein is the offending agent. This presentation focuses on food-induced asthma and milk-induced chronic pulmonary disease in infants.